Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.360
-0.070 (-2.04%)
At close: May 29, 2026, 4:00 PM EDT
3.400
+0.040 (1.19%)
After-hours: May 29, 2026, 7:52 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Biotechnology
588.90M491.98M93.38M85.02M39.68M
Biotechnology Growth
19.70%426.84%9.84%114.23%-42.86%
Total
588.90M491.98M93.38M85.02M39.68M
Total Growth
19.70%426.84%9.84%114.23%-42.86%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Europe
307.22M157.59M63.51M39.43M20.51M
Europe Growth
94.95%148.13%61.06%92.27%4.05%
Usa
241.37M273.04M9.43M17.94M-
Usa Growth
-11.60%2795.40%-47.44%--
Other Geographies
37.73M59.06M18.49M25.66M-
Other Geographies Growth
-36.11%219.34%-27.92%--
North America
----11.66M
North America Growth
-----69.26%
Asia and Other
----4.60M
Total
586.32M489.68M91.43M83.03M36.77M
Total Growth
19.74%435.56%10.12%125.79%-44.80%
Source: S&P Global Market Intelligence.